In this inaugural episode, Dr. Niraj Sharma breaks down three pivotal studies that could shift daily EP practice:

• How high-normal potassium targeting can reduce VT burden (POT-CAST trial).
• When GDMT withdrawal may be safe after recovery from tachycardia-induced cardiomyopathy.
• Why adverse pregnancy outcomes may predict long-term AF risk.

Get the signal — not the noise — with expert analysis, clinical context, and practical takeaways for the EP lab.